Blood for Immune Response to Provenge® in HRPC
| Status: | Archived |
|---|---|
| Conditions: | Prostate Cancer, Cancer, Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases, Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | January 2011 |
Blood Samples to Evaluate Immune Response to Provenge® (Sipuleucel-T) inHormone Refractory Metastatic Prostate Cancer Patients
This study is being conducted to assess and monitor immune response in patients with
minimally symptomatic or asymptomatic hormone refractory prostate cancer who will be
receiving Provenge® (Sipuleucel-T) therapy as part of their standard of care treatment
regimen. The trial only involves the collection of additional blood samples for the
purposes of monitoring immune response. These samples will be taken at 7 time points
before, during and after patients receive Provenge® (Sipuleucel-T). There will be no other
study-specific procedures performed (other than the blood draws) nor any use of
investigational agents in this study.
We found this trial at
1
site
Click here to add this to my saved trials
